JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma

F Liang, Z Li, P Huang - International immunopharmacology, 2020 - Elsevier
Kidney renal clear cell carcinoma (KIRC) is one of the most common cancers globally, with
an overall poor prognosis. The Janus kinase (JAK) family plays an essential role in cellular …

[HTML][HTML] PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma

C Qin, S Liu, S Zhou, Q Wang, X Xia, J Hu… - Frontiers in …, 2023 - frontiersin.org
Background Phosphoinositide 3-kinases (PI3Ks) are lipid enzymes that regulate a wide
range of intracellular functions. In contrast to Class I and Class III PI3K, which have more …

IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma

Y Liu, Z Xing, M Yuan, B Xu, L Chen, D Zhang… - … -Research and Practice, 2022 - Elsevier
Clear cell renal cell carcinoma (ccRCC) is known as the most aggressive subtype of
genitourinary cancers. The lack of effective therapies has prompted us to further explore the …

[HTML][HTML] SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma

H Feng, T Wang, J Ye, Y Yang, X Huang, D Lai, Z Lv… - Discover Oncology, 2022 - Springer
Abstract Background Spi-1 proto-oncogene (SPI1), which encodes an ETS-domain
transcription factor, can activate gene expression in myeloid and lymphoid lineages. The …

JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in CD8+ T Cells in Renal Cell Carcinoma Patients

E Cavalcanti, M Gigante, V Mancini… - BioMed Research …, 2010 - Wiley Online Library
To investigate the molecular mechanisms underlying altered T cell response in renal cell
carcinoma (RCC) patients, we compared autologous and allogeneic CD8+ T cell responses …

JAK3 in clear cell renal cell carcinoma: mutational screening and clinical implications

M de Martino, M Gigante, L Cormio… - … Oncology: Seminars and …, 2013 - Elsevier
Abstract Objectives Janus Kinase 3 (JAK3) mediates cytokine signaling and T-cell activation.
We hypothesized that JAK3 mutations may contribute to the development and progression of …

[HTML][HTML] Interleukin4Rα (IL4Rα) and IL13Rα1 are associated with the progress of renal cell carcinoma through janus kinase 2 (JAK2)/forkhead box O3 (FOXO3) …

MA Kang, J Lee, SH Ha, CM Lee, KM Kim, KY Jang… - Cancers, 2019 - mdpi.com
Specific kinds of interleukin (IL) receptors are known to mediate lymphocyte proliferation and
survival. However, recent reports have suggested that the high expression of IL4Rα and …

[HTML][HTML] Development and validation of an IL6/JAK/STAT3-related gene signature to predict overall survival in clear cell renal cell carcinoma

C Zhan, C Xu, J Chen, C Shen, J Li, Z Wang… - Frontiers in Cell and …, 2021 - frontiersin.org
Background: Traditional clinicopathological features (TNM, pathology grade) are often
insufficient in predictive prognosis accuracy of clear cell renal cell carcinoma (ccRCC). The …

JAK2 expression is correlated with the molecular and clinical features of breast cancer as a favorable prognostic factor

Q Liu, B Ai, X Kong, X Wang, Y Qi, Z Wang… - International …, 2021 - Elsevier
Janus kinases are a family of non-receptor tyrosine kinases involved in autoimmune
diseases and malignancies. In breast cancer, the immune related role of JAK2 remains …

[HTML][HTML] Prognostic significance of PI3K/AKT/mTOR signaling pathway members in clear cell renal cell carcinoma

D Fan, Q Liu, F Wu, N Liu, H Qu, Y Yuan, Y Li, H Gao… - PeerJ, 2020 - peerj.com
Background Renal cell carcinoma (RCC) is a fatal disease, in which the PI3K/AKT/mTOR
signaling pathway serves an important role in the tumorigenesis. Previous studies have …